Oncology cytogenetics at The Christie Pathology Partnership is a specialist regional service, which provides genetic testing to aid diagnosis of leukaemia and other tumours.
Malignant diseases are often classified by their genetic abnormalities and certain cytogenetic tests are essential for the optimal diagnosis and treatment stratification of cancer patients. Increasingly, cancer drugs are being developed that target specific genetic lesions, which therefore require a predictive genetic test.
The department is the nominated service for leukaemia cytogenetics for local cancer networks. We work closely with specialist Histopathology departments to provide FISH testing for the diagnosis of various solid tumours and are continually developing assays to expand the diagnostic FISH service. We would be delighted to discuss your genetic testing requirements.
The Oncology Cytogenetics laboratory is UKAS accredited (ref. no. 8697), complies with professional standards issued by the Association for Clinical Genetic Science (ACGS) and participates in all relevant EQA schemes (GENQA/UKNEQAS).
- Cytogenetics and FISH Services for haemato-oncology
- Molecular cytogenetics (FISH) for solid tumours
- Immunohistochemistry and FISH for breast tumours
- Molecular Genetics
General enquiries: 0161 446 3165
Nick Telford, consultant clinical scientist, firstname.lastname@example.org